Effects and safety of allogenic mesenchymal stem cell intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: a 20-week clinical trial.
Wang P, Li Y, Huang L, Yang J, Yang R, Deng W, Liang B, Dai L, Meng Q, Gao L, Chen X, Shen J, Tang Y, Zhang X, Hou J, Ye J, Chen K, Cai Z, Wu Y, Shen H.
Wang P, et al. Among authors: hou j.
Cell Transplant. 2014;23(10):1293-303. doi: 10.3727/096368913X667727. Epub 2013 May 22.
Cell Transplant. 2014.
PMID: 23711393
Free article.
Clinical Trial.